Home / breaking news / The Hindu - Home / Covaxin safe, shows 77.8% efficacy against symptomatic COVID-19: Lancet study

Covaxin safe, shows 77.8% efficacy against symptomatic COVID-19: Lancet study

,
Covaxin recently received emergency use approval from the World Health Organization.

from The Hindu - Home https://ift.tt/3n6AXwR
https://ift.tt/eA8V8J
Covaxin safe, shows 77.8% efficacy against symptomatic COVID-19: Lancet study Covaxin safe, shows 77.8% efficacy against symptomatic COVID-19: Lancet study Reviewed by rana news on November 12, 2021 Rating: 5

You May Also Like

No comments:

Subscribe to: Post Comments ( Atom )
Powered by Blogger.